Retrocollis: Classification, clinical phenotype, treatment outcomes and risk factors

European Neurology

Volumn 59, Issue 1-2, 2007, Pages 71-75

  Papapetropoulos, Spiridon ^a   Baez, Sheila ^a   Zitser, Jennifer ^a   Sengun, Cenk ^a   Singer, Carlos ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Botulinum toxin; Cervical dystonia; Clinical characteristics; Retrocollis; Risk factors

Indexed keywords

ANTIEMETIC AGENT; BACLOFEN; BENZATROPINE; BOTULINUM TOXIN A; CLONAZEPAM; NEUROLEPTIC AGENT; TRIHEXYPHENIDYL;

ADULT; ARTICLE; CERVICAL DYSTONIA; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DYSTONIA; FEMALE; HEAD AND NECK INJURY; HEADACHE; HUMAN; INJECTION; INJECTION SITE IRRITATION; MAJOR CLINICAL STUDY; MALE; MUSCLE SPASM; NARCOLEPSY; PAIN; PHENOTYPE; PRIORITY JOURNAL; RETROCOLLIS; RISK FACTOR; SYMPTOM; TREATMENT OUTCOME;

ADULT; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; TORTICOLLIS; TREATMENT OUTCOME;

EID: 37249031830     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109265     Document Type: Article

References (29)

1. Fahn S, Marsden CD, Calne DB: Classification and investigation of dystonia; in Fahn S, Marsden CD (eds): Movement disorders 2. London, Butterworth and Co, 1987, pp 332-358.
2. Defazio G, Abbruzzese G, Livrea P, Berardelli A: Epidemiology of primary dystonia. Lancet Neurol 2004;3:673-678.
3. Dauer WT, Burke RE, Greene P, Fahn S: Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. Brain 1998;121:547-560.
4. Jankovic J, Leder S, Warner D, Schwartz K: Cervical dystonia: clinical findings and associated movement disorders. Neurology 1991;41:1088-1091.
5. Fernandez HH, Friedman JH: Classification and treatment of tardive syndromes. Neurologist 2003;9:16-27.
6. Müller J, Wenning GK, Wissel J, Seppi K, Poewe W: Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia. J Neurol 2002;249:300-304.
7. Poewe W, Deuschl G, Nebe A, Feifel E, Wissel J, Benecke R, et al: What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group. J Neurol Neurosurg Psychiatry 1998;64:13-17.
8. Brashear A, Lew MF, Dykstra DD, Comella CL, Factor SA, Rodnitzky RL, et al: Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 1999;53:1439-1446.
9. Comella CL, Jankovic J, Shannon KM, Tsui J, Swenson M, Leurgans S, et al: Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology 2005;65:1423-1429.
10. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J: Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985;35:73-77.
11. Claypool DW, Duane DD, Ilstrup DM, Melton LJ 3rd: Epidemiology and outcome of cervical dystonia (spasmodic torticollis) in Rochester, Minnesota. Mov Disord 1995;10:608-614.
12. Kang UJ, Burke RE, Fahn S: Natural history and treatment of tardive dystonia. Mov Disord 1986;1:193-208.
13. Weiner WJ: Can peripheral trauma induce dystonia? No! Mov Disord 2001;16:13-22.
14. Samii A, Pal PK, Schulzer M, Mak E, Tsui JK: Post-traumatic cervical dystonia: a distinct entity? Can J Neurol Sci 2000;27:55-59.
15. O'Riordan S, Hutchinson M: Cervical dystonia following peripheral trauma - a case-control study. J Neurol 2004;251:150-155.
16. Jankovic J: Can peripheral trauma induce dystonia and other movement disorders? Yes! Mov Disord 2001;16:7-12.
17. Jankovic J: Post-traumatic movement disorders: central and peripheral mechanisms. Neurology 1994;44:2006-2014.
18. Kutvonen O, Dastidar P, Nurmikko T: Pain in spasmodic torticollis. Pain 1997;69:279-286.
19. Rosenbaum F, Jankovic J: Focal task-specific tremor and dystonia: categorization of occupational movement disorders. Neurology 1988;38:522-527.
20. Loher TJ, Bärlocher CB, Krauss JK: Dystonic movement disorders and spinal degenerative disease. Stereotact Funct Neurosurg 2006;84:1-11.
21. Dickerman RD, Reynolds AS: Postoperative cervical dystonia: is it an occult injury to the corticospinal tracts? Stereotact Funct Neurosurg 2006;84:125.
22. Takemoto M, Ikenaga M, Tanaka C, Sonobe M, Shikata J: Cervical dystonia induced by cervical spine surgery: a case report. Spine 2006;31:E31-E34.
23. Boesch SM, Wenning GK, Ransmayr G, Poewe W: Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002;72:300-303.
24. Singer C, Papapetropoulos S, Ayyar DR, Verma A: Botulinum toxin type A therapy in a patient with cervical dystonia and amyotrophic lateral sclerosis. Mov Disord 2007; in press.
25. Comella CL, Jankovic J, Brin MF: Use of botulinum toxin type A in the treatment of cervical dystonia. Neurology 2000;55(12 suppl 5):S15-S21.
26. Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Benabid AL, Cornu P, et al: Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 2005;352:459-467.
27. Kupsch A, Benecke R, Müller J, Trottenberg T, Schneider GH, Poewe W, et al: Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 2006;355:1978-1990.
28. Hung SW, Hamani C, Lozano AM, Poon YY, Piboolnurak P, Miyasaki JM, et al: Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia. Neurology 2007;68:457-459.
29. Cohen OS, Hassin-Baer S, Spiegelmann R: Deep brain stimulation of the internal globus pallidus for refractory tardive dystonia. Parkinsonism Relat Disord 2007; Epub.